Omega Therapeutics (OMGA)
Omega Therapeutics, Inc. operates as a clinical-stage biotechnology company. The company’s OMEGA platform enables control of fundamental epigenetic processes to...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- 0.1426
- Volume
- 0
- Turnover
- 0
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- 0.00
- Turnover Ratio
- --
News
- Pharmaceutical Business Review · 2 hours ago
Charles River and MVC to develop enterovirus vaccine
- TechCrunch · 1 day ago, 07:06 AM
AI isn’t close to curing cancer. This startup says it knows what it will take.
- PUBT · 2 days ago, 03:26 AM
Oncoinvent publishes investor presentation on Radspherin alpha therapy for peritoneal metastases
- PUBT · 2 days ago, 07:55 AM
Conexeu says CXU preclinical program completes 12-month P..O.F. phase, meets objectives
- Tip Ranks · Mar 11 at 11:13 PM
Omega Oil & Gas Releases Interim Half-Year Financial Report
- Market Beat · Feb 18 at 02:09 AM
Omega Flex (NASDAQ:OFLX) Shares Pass Above 200-Day Moving Average - Here's What Happened
